Prof Michael Dickinson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
271 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
DOI: 10.1182/blood.20250323072026
Journal article
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.
DOI: 10.1182/bloodadvances.20260201232026
Journal article
Glofitamab monotherapy in patients with Richter's transformation: safety and efficacy from a phase 1 study.
DOI: 10.1182/bloodadvances.20250181592026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
DOI: 10.1182/blood.20250308722022
Research grants (other domestic)
Novel Strategies to Predict and Monitor Response to CAR T-Cell Therapy in DLBCL
2019
Journal article
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
DOI: 10.1111/bjh.16069
RECENT SCHOLARLY WORKS
2026
Journal article
Web-Based Cognitive Rehabilitation for Patients With Aggressive Lymphoma With Perceived Cognitive Impairment: A Randomised Pilot Study
DOI: 10.1002/pon.704692026
Journal article
Five-Year Update of the Phase 2 ELARA Trial of Tisagenlecleucel in Patients (pts) with relapsed/refractory Follicular Lymphoma (r/r FL)
DOI: 10.1016/j.jtct.2025.12.0772026
Journal article
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy
DOI: 10.1177/175628642514044642026
Journal article
Bispecific antibody combination therapies in diffuse large B-cell lymphoma
DOI: 10.1111/bjh.702282026
Journal article
Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era
DOI: 10.1111/bjh.70451